Capital adjustments - Correction*
March 10, 2003 04:42 ET
|
Frontline plc.
One employee of Frontline has exercised options to acquire a total of 10,000 shares in Frontline. All shares have been acquired at a strike price of NOK 28.66 per share. Total proceeds were...
Miscellaneous
March 10, 2003 04:39 ET
|
Frontline plc.
One employee of Frontline has exercised options to acquire a total of 10,000 shares in Frontline. All shares have been acquired at a strike price of NOK 28.66 per share. Total proceeds were...
Frontline: Share Acquisition
March 10, 2003 04:19 ET
|
Frontline Ltd.
HAMILTON, Bermuda, March 10, 2003 (PRIMEZONE) -- One employee of Frontline (NYSE:FRO) has exercised options to acquire a total of 10,000 shares in Frontline. All shares have been acquired at a strike...
FDA Fast Track Designation for Basilea's Novel Broad Spectrum Antibiotic
March 10, 2003 04:16 ET
|
Basilea Pharmaceutica Ltd
BASEL, Switzerland, March, 10, 2003 (PRIMEZONE) -- Basilea Pharmaceutica Ltd. today announced that it has received fast track designation from the U.S. Food and Drug Administration (FDA) for its...
Capital adjustments
March 10, 2003 04:07 ET
|
Frontline plc.
One employee of Frontline has exercised options to acquire a total of 10,000 shares in Frontline. All shares have been acquired at a strike price of NOK 28.66 per share. Total proceeds were...
Miscellaneous
March 10, 2003 04:05 ET
|
Frontline plc.
One employee of Frontline has exercised options to acquire a total of 10,000 shares in Frontline. All shares have been acquired at a strike price of NOK 28.66 per share. Total proceeds were NOK...
SPONDA OYJ: ILMOITUS OMISTUSOSUUDEN MUUTTUMISESTA
March 10, 2003 04:00 ET
|
Sponda Oy
Ilmoitamme tietoomme tulleen, että Fidelity International Limitedin ja sen hallinnoimien rahastojen yhteinen omistusosuus Sponda Oyj:n (Y-tunnus 866692-3) osakepääomasta ja äänimäärästä on alittanut...
Sponda Plc - NOTIFICATION OF CHANGE IN OWNERSHIP
March 10, 2003 04:00 ET
|
Sponda Oy
According to information we have received, the aggregate holding of shares by Fidelity International Limited and its trust funds in Sponda Plc (Reg. No. 866692-3) has decreased below one-twentieth of...
FDA Fast Track Designation for Basilea's Novel Broad Spectrum Antibiotic
March 10, 2003 04:00 ET
|
Basilea Pharmaceutica AG
Basilea Pharmaceutica Ltd announced today that it has received fast track designation from the U.S. Food and Drug Administration (FDA) for its novel broad-spectrum cephalosporin antibiotic BAL5788,...
Amerikanische Gesundheitsbehörde bewilligt dem Schweizer Pharmaunternehmen Basilea Pharmaceutica "fast track status"
March 10, 2003 04:00 ET
|
Basilea Pharmaceutica AG
Der wachsende Anteil von Bakterien, die gegenüber den heute verfügbaren Antibiotika resistent sind, stellt insbesondere bei schweren Krankenhausinfektionen eine weltweite Bedrohung dar. Allein in den...